MGMT-NET: O6-methylguanine-DNA Methyltransferase (MGMT) Status in Neuroendocrine Tumors: Predictive Factor of Response to Alkylating Agents
Clinical trial NCT03217097 · COMPLETED
Trial details
- NCT number
- NCT03217097
- Sponsor
- Hospices Civils de Lyon
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-16
- Primary completion
- 2022-01-31
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.